{
    "Trade/Device Name(s)": [
        "A/C Portable Enzymatic Homocysteine Assay",
        "A/C Portable Enzymatic Homocysteine Assay on the A/C Diagnostics Reader"
    ],
    "Submitter Information": "AntiCancer Inc.",
    "510(k) Number": "K080851",
    "Predicate Device Reference 510(k) Number(s)": [
        "K030754"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LPS"
    ],
    "Summary Letter Date": "October 10, 2008",
    "Summary Letter Received Date": "September 25, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1377"
    ],
    "Regulation Name(s)": [
        "Urinary Homocysteine Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total homocysteine (tHCY)"
    ],
    "Specimen Type(s)": [
        "Plasma",
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "A/C Diagnostics Reader (HyTek-205)"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Enzymatic quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for A/C Portable Enzymatic Homocysteine Assay on A/C Diagnostics Reader for quantitation of total homocysteine in human plasma or serum.",
    "Indications for Use Summary": "Quantitative determination of total homocysteine in human plasma or serum to assist in diagnosing and treating suspected hyperhomocysteinemia; for in vitro diagnostic use.",
    "fda_folder": "Clinical Chemistry"
}